Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- Compugen reported a quarterly loss of $0.08 per share, beating estimates by 20%. - Revenues for the quarter totaled $2.56 million, missing estimates by 8.28%. - Compugen shares have gained 6.6% this year, underperforming the S&P 500. - Estimate revisions trend for Compugen is currently mixed, with a Zacks Rank #3 (Hold). - Industry outlook can impact stock performance, Medical - Biomedical and Genetics ranks in top 35%. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Research Analysis
- Compugen reported a quarterly loss of $0.08 per share, beating estimates by 20%.
- Revenues for the quarter totaled $2.56 million, missing estimates by 8.28%.
- Compugen shares have gained 6.6% this year, underperforming the S&P 500.
- Estimate revisions trend for Compugen is currently mixed, with a Zacks Rank #3 (Hold).
- Industry outlook can impact stock performance, Medical - Biomedical and Genetics ranks in top 35%.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.